Related references
Note: Only part of the references are listed.Combustion-derived particles from biomass sources differently promote epithelial-to-mesenchymal transition on A549 cells
Sara Marchetti et al.
ARCHIVES OF TOXICOLOGY (2021)
Competition between PRC2.1 and 2.2 subcomplexes regulates PRC2 chromatin occupancy in human stem cells
Daniel T. Youmans et al.
MOLECULAR CELL (2021)
Gene regulation by long non-coding RNAs and its biological functions
Luisa Statello et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2021)
Bulges control pri-miRNA processing in a position and strand-dependent manner
Shaohua Li et al.
RNA BIOLOGY (2021)
LncRNA HOTAIR recruits SNAIL to inhibit the transcription of HNF4α and promote the viability, migration, invasion and EMT of colorectal cancer
Long Jin et al.
TRANSLATIONAL ONCOLOGY (2021)
A quantitative map of human primary microRNA processing sites
Kijun Kim et al.
MOLECULAR CELL (2021)
NCK1-AS1 promotes NCK1 expression to facilitate tumorigenesis and chemo-resistance in ovarian cancer
Hua Chang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Long Noncoding RNA TUG I Promotes Autophagy-Associated Paclitaxel Resistance by Sponging miR-29b-3p in Ovarian Cancer Cells
Lize Gu et al.
ONCOTARGETS AND THERAPY (2020)
Long Non-coding RNA CCAT1 Sponges miR-454 to Promote Chemoresistance of Ovarian Cancer Cells to Cisplatin by Regulation of Surviving
De-Ying Wang et al.
CANCER RESEARCH AND TREATMENT (2020)
circCELSR1 (hsa-circ-0063809) Contributes to Paclitaxel Resistance of Ovarian Cancer Cells by Regulating FOXR2 Expression via miR-1252
Shu Zhang et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
Long noncoding RNA mediates stroke-induced neurogenesis
Baoyan Fan et al.
STEM CELLS (2020)
NEAT1 Knockdown Suppresses the Cisplatin Resistance in Ovarian Cancer by Regulating miR-770-5p/PARP1 Axis
Mingzhe Zhu et al.
CANCER MANAGEMENT AND RESEARCH (2020)
The contribution of copper efflux transporters ATP7A and ATP7B to chemoresistance and personalized medicine in ovarian cancer
David Lukanovic et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Circular RNA circTNPO3 Regulates Paclitaxel Resistance of Ovarian Cancer Cells by miR-1299/NEK2 Signaling Pathway
Bing Xia et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
Downregulation of circNRIP I Suppresses the Paclitaxel Resistance of Ovarian Cancer via Regulating the miR-2 I I-5p/HOXC8 Axis
Meng Li et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Targeting autophagy to overcome drug resistance: further developments
Haocai Chang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Circulating exosomal circFoxp1 confers cisplatin resistance in epithelial ovarian cancer cells
Yanwei Luo et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2020)
The Long Non-Coding RNA MALAT1 Enhances Ovarian Cancer Cell Sternness by Inhibiting YAP Translocation from Nucleus to Cytoplasm
XingMei Wu et al.
MEDICAL SCIENCE MONITOR (2020)
Knockdown of long non-coding RNA HOTAIR reverses cisplatin resistance of ovarian cancer cells through inhibiting miR-138-5p-regulated EZH2 and SIRT1
Yun Zhang et al.
BIOLOGICAL RESEARCH (2020)
Copy Number Amplification of DNA Damage Repair Pathways Potentiates Therapeutic Resistance in Cancer
Zhiyuan Wu et al.
THERANOSTICS (2020)
miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancer
Jing Sun et al.
ONCOGENE (2019)
The Landscape of Circular RNA in Cancer
Josh N. Vo et al.
CELL (2019)
Macrophages derived exosomes deliver miR-223 to epithelial ovarian cancer cells to elicit a chemoresistant phenotype
Xiaolan Zhu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
MiR-1180 from bone marrow-derived mesenchymal stem cells induces glycolysis and chemoresistance in ovarian cancer cells by upregulating the Wnt signaling pathway
Zhuo-wei Gu et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2019)
HIF Inactivation of p53 in Ovarian Cancer Can Be Reversed by Topotecan, Restoring Cisplatin and Paclitaxel Sensitivity
Basmina Parmakhtiar et al.
MOLECULAR CANCER RESEARCH (2019)
Mechanism of allosteric modulation of P-glycoprotein by transport substrates and inhibitors
Reza Dastvan et al.
SCIENCE (2019)
Expression levels of MRP1, GST-π, and GSK3β in ovarian cancer and the relationship with drug resistance and prognosis of patients
Xiaojing Tong et al.
ONCOLOGY LETTERS (2019)
LncRNA ANRIL affects the sensitivity of ovarian cancer to cisplatin via regulation of let-7a/HMGA2 axis
Jin-Tian Miao et al.
BIOSCIENCE REPORTS (2019)
The biogenesis, biology and characterization of circular RNAs
Lasse S. Kristensen et al.
NATURE REVIEWS GENETICS (2019)
SNHG22 overexpression indicates poor prognosis and induces chemotherapy resistance via the miR-2467/Gal-1 signaling pathway in epithelial ovarian carcinoma
Peng-Fei Zhang et al.
AGING-US (2019)
Overexpression of Long Noncoding RNA E2F-Mediated Cell Proliferation Enhancing Long Noncoding RNA Is Involved in the Development of Chemoresistance of Cancer Cells to Carboplatin in Ovarian Endometrioid Adenocarcinoma
Lei Zhao et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2019)
Phase 1 study of veliparib (ABT-888), a poly (ADP-ribose) polymerase inhibitor, with carboplatin and paclitaxel in advanced solid malignancies
Leonard J. Appleman et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2019)
The Role of Non-coding RNAs in Oncology
Frank J. Slack et al.
CELL (2019)
Targeting COX-1 by mofezolac-based fluorescent probes for ovarian cancer detection
Antonio Scilimati et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
MiR-1307 influences the chemotherapeutic sensitivity in ovarian cancer cells through the regulation of the CIC transcriptional repressor
Yingying Zhou et al.
PATHOLOGY RESEARCH AND PRACTICE (2019)
Thyroid hormone induces progression and invasiveness of squamous cell carcinomas by promoting a ZEB-1/E-cadherin switch
Caterina Miro et al.
NATURE COMMUNICATIONS (2019)
Landscape of systemic therapy for ovarian cancer in 2019: Primary therapy
Keiichi Fujiwara et al.
CANCER (2019)
Cancer stem cells (CSCs) in cancer progression and therapy
Masoud Najafi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Core fucosylation of copper transporter 1 plays a crucial role in cisplatin-resistance of epithelial ovarian cancer by regulating drug uptake
Xiaoxue Lv et al.
MOLECULAR CARCINOGENESIS (2019)
New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer
Anushka Dongre et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
NF1 regulates apoptosis in ovarian cancer cells by targeting MCL1 via miR-142-5p
Jiancheng Su et al.
PHARMACOGENOMICS (2019)
Role of EZH2 in cell lineage determination and relative signaling pathways
Aalia Batool et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2019)
ANRIL regulates production of extracellular matrix proteins and vasoactive factors in diabetic complications
Anu Alice Thomas et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2018)
MicroRNA-630 inhibitor sensitizes chemoresistant ovarian cancer to chemotherapy by enhancing apoptosis
Kyung Jin Eoh et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
UCA1 confers paclitaxel resistance to ovarian cancer through miR-129/ABCB1 axis
Junrong Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
The effect of lncRNA HOTAIR on chemoresistance of ovarian cancer through regulation of HOXA7
Siwei Liu et al.
BIOLOGICAL CHEMISTRY (2018)
How the Warburg effect supports aggressiveness and drug resistance of cancer cells?
Philippe Icard et al.
DRUG RESISTANCE UPDATES (2018)
Knockdown of MALAT1 enhances chemosensitivity of ovarian cancer cells to cisplatin through inhibiting the Notch1 signaling pathway
Lin Bai et al.
EXPERIMENTAL CELL RESEARCH (2018)
miR-149-5p promotes chemotherapeutic resistance in ovarian cancer via the inactivation of the Hippo signaling pathway
Manman Xu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
Advanced siRNA Designs Further Improve In Vivo Performance of GaINAc-siRNA Conjugates
Donald J. Foster et al.
MOLECULAR THERAPY (2018)
Dicer cleaves 5′-extended microRNA precursors originating from RNA polymerase II transcription start sites
Peike Sheng et al.
NUCLEIC ACIDS RESEARCH (2018)
Construction and investigation of lncRNA-associated ceRNA regulatory network in papillary thyroid cancer
Yangjing Zhao et al.
ONCOLOGY REPORTS (2018)
STAT3 regulated miR-216a promotes ovarian cancer proliferation and cisplatin resistance
Pengfei Jin et al.
BIOSCIENCE REPORTS (2018)
The cisplatin-induced lncRNA PANDAR dictates the chemoresistance of ovarian cancer via regulating SFRS2-mediated p53 phosphorylation
Hao Wang et al.
CELL DEATH & DISEASE (2018)
Glutathione S-transferase π: a potential role in antitumor therapy
Shu-Chen Dong et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
LINC01118 Modulates Paclitaxel Resistance of Epithelial Ovarian Cancer by Regulating miR-134/ABCC1
Cong Shi et al.
MEDICAL SCIENCE MONITOR (2018)
SLC27A2 regulates miR-411 to affect chemo-resistance in ovarian cancer
F. D. Chen et al.
NEOPLASMA (2018)
Comparative transcriptome analysis of isogenic cell line models and primary cancers links capicua (CIC) loss to activation of the MAPK signalling cascade
Veronique G. LeBlanc et al.
JOURNAL OF PATHOLOGY (2017)
Mechanistic insights into caspase-9 activation by the structure of the apoptosome holoenzyme
Yini Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
LncRNA NEAT1 contributes to paclitaxel resistance of ovarian cancer cells by regulating ZEB1 expression via miR-194
Jihong An et al.
ONCOTARGETS AND THERAPY (2017)
miRNA-21 enhances chemoresistance to cisplatin in epithelial ovarian cancer by negatively regulating PTEN
Xiaomin Yu et al.
ONCOLOGY LETTERS (2017)
Long non-coding RNA ZFAS1 interacts with miR-150-5p to regulate Sp1 expression and ovarian cancer cell malignancy
Bairong Xia et al.
ONCOTARGET (2017)
IL-6R/STAT3/miR-204 feedback loop contributes to cisplatin resistance of epithelial ovarian cancer cells
Xiaolan Zhu et al.
ONCOTARGET (2017)
Upregulation of MiR-205 transcriptionally suppresses SMAD4 and PTEN and contributes to human ovarian cancer progression
Juanni Li et al.
SCIENTIFIC REPORTS (2017)
Acquired chemotherapy resistance in ovarian cancer
E. L. Christie et al.
ANNALS OF ONCOLOGY (2017)
Hmga2 collaborates with JAK2V617F in the development of myeloproliferative neoplasms
Koki Ueda et al.
BLOOD ADVANCES (2017)
Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: first-line interventions
A. Karam et al.
ANNALS OF ONCOLOGY (2017)
Overexpression of long non-coding RNA HOTAIR leads to chemoresistance by activating the Wnt/β-catenin pathway in human ovarian cancer
Jing Li et al.
TUMOR BIOLOGY (2016)
Crosstalk between tumor suppressors p53 and PKCδ: Execution of the intrinsic apoptotic pathways
Nurmaa Dashzeveg et al.
CANCER LETTERS (2016)
The loss of Ezh2 drives the pathogenesis of myelofibrosis and sensitizes tumor-initiating cells to bromodomain inhibition
Goro Sashida et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
General rules for functional microRNA targeting
Doyeon Kim et al.
NATURE GENETICS (2016)
NF-κB-HOTAIR axis links DNA damage response, chemoresistance and cellular senescence in ovarian cancer
A. R. Ozes et al.
ONCOGENE (2016)
Long noncoding RNA uc.338 promotes cell proliferation through association with BMI1 in hepatocellular carcinoma
Changwen Bo et al.
HUMAN CELL (2016)
Anti-tumor Efficiency of Lipid-coated Cisplatin Nanoparticles Co-loaded with MicroRNA-375
Tan Yang et al.
THERANOSTICS (2016)
Survivin and Tumorigenesis: Molecular Mechanisms and Therapeutic Strategies
Xun Chen et al.
JOURNAL OF CANCER (2016)
Berberine Sensitizes Human Ovarian Cancer Cells to Cisplatin Through miR-93/PTEN/Akt Signaling Pathway
Qiaoyun Chen et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
HOTAIR is a potential target for the treatment of cisplatin-resistant ovarian cancer
Yu Wang et al.
MOLECULAR MEDICINE REPORTS (2015)
SUZ12 promotes gastric cancer cell proliferation and metastasis by regulating KLF2 and E-cadherin
Rui Xia et al.
TUMOR BIOLOGY (2015)
Differential retrotranslocation of mitochondrial Bax and Bak
Franziska Todt et al.
EMBO JOURNAL (2015)
MiR-130a and MiR-374a Function as Novel Regulators of Cisplatin Resistance in Human Ovarian Cancer A2780 Cells
Ningwei Li et al.
PLOS ONE (2015)
Involvement of SRPK1 in cisplatin resistance related to long non-coding RNA UCA1 in human ovarian cancer cells
F. Wang et al.
NEOPLASMA (2015)
Wnt signaling directs a metabolic program of glycolysis and angiogenesis in colon cancer
Kira T. Pate et al.
EMBO JOURNAL (2014)
BAG3 upregulates Mcl-1 through downregulation of miR-29b to induce anticancer drug resistance in ovarian cancer
Asuka Sugio et al.
GYNECOLOGIC ONCOLOGY (2014)
HOXA9 promotes homotypic and heterotypic cell interactions that facilitate ovarian cancer dissemination via its induction of P-cadherin
Song Yi Ko et al.
MOLECULAR CANCER (2014)
Regulation of microRNA biogenesis
Minju Ha et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Upregulation of NEK2 is associated with drug resistance in ovarian cancer
Xia Liu et al.
ONCOLOGY REPORTS (2014)
Effects of HMGA2 on malignant degree, invasion, metastasis, proliferation and cellular morphology of ovarian cancer cells
Yan-Ni Xi et al.
ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE (2014)
Galectin-1 overexpression promotes progression and chemoresistance to cisplatin in epithelial ovarian cancer
P. Zhang et al.
CELL DEATH & DISEASE (2014)
microRNA-106a modulates cisplatin sensitivity by targeting PDCD4 in human ovarian cancer cells
Hao Li et al.
ONCOLOGY LETTERS (2014)
Essential role of lncRNA binding for WDR5 maintenance of active chromatin and embryonic stem cell pluripotency
Yul W. Yang et al.
ELIFE (2014)
FGF-2 prevents cancer cells from ER stress-mediated apoptosis via enhancing proteasome-mediated Nck degradation
Bin Li et al.
BIOCHEMICAL JOURNAL (2013)
Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer
J. H. Huh et al.
BRITISH JOURNAL OF CANCER (2013)
Genome-Wide and Species-Wide In Silico Screening for Intragenic MicroRNAs in Human, Mouse and Chicken
Irena Godnic et al.
PLOS ONE (2013)
Staufen-mediated mRNA decay
Eonyoung Park et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2013)
Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells
Xin Fu et al.
FEBS LETTERS (2012)
The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and lgf1r
Andrew Keniry et al.
NATURE CELL BIOLOGY (2012)
ΔNp63α Confers Tumor Cell Resistance to Cisplatin through the AKT1 Transcriptional Regulation
Tanusree Sen et al.
CANCER RESEARCH (2011)
miR-125b confers resistance of ovarian cancer cells to cisplatin by targeting pro-apoptotic Bcl-2 antagonist killer 1
Fanfei Kong et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2011)
lncRNAs transactivate STAU1-mediated mRNA decay by duplexing with 3′ UTRs via Alu elements
Chenguang Gong et al.
NATURE (2011)
MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells
Zhimin Li et al.
GYNECOLOGIC ONCOLOGY (2010)
Long Noncoding RNA as Modular Scaffold of Histone Modification Complexes
Miao-Chih Tsai et al.
SCIENCE (2010)
Inhibition of HIF-Ialpha activity by homeodomain-interacting protein kinase-2 correlates with sensitization of chemoresistant cells to undergo apoptosis
Lavinia Nardinocchi et al.
MOLECULAR CANCER (2009)
MicroRNA expression profiling in human ovarian cancer:: miR-214 induces cell survival and cisplatin resistance by targeting PTEN
Hua Yang et al.
CANCER RESEARCH (2008)
The eukaryotic genome as an RNA machine
Paulo P. Amaral et al.
SCIENCE (2008)
Crucial roles of Sp1 and epigenetic modifications in the regulation of the CLDN4 promoter in ovarian cancer cells
Hiroshi Honda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The significance of the Wnt pathway in the pathology of human cancers
RZ Karim et al.
PATHOLOGY (2004)
Share Paper
